TrialDiabetes, obesity & metabolism2017

Effects of β-blockers on all-cause mortality in patients with type 2 diabetes and coronary heart disease.

Tetsuro Tsujimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.